Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 18, 2018
Janssen has entered a new worldwide collaboration with Bristol-Myers Squibb on a program to develop and commercialize Factor XIa inhibitors, including BMS-986177.
read more
JanOne has selected its bottling and labeling partner to support upcoming clinical trials.
read more
Friday, September 04, 2020
JanOne has confirmed stability of its developmental batch run of JAN101.
read more
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more
Wednesday, November 27, 2019
JanOne has announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease.
read more
ValSource announced Dr. James Vesper has joined as a Director, Learning Solutions.
read more
Wednesday, September 30, 2015
Jaguar Animal Health, an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, has signed a four-year manufacturing and supply agreement with Glenmark ...
read more
Jacobs has been selected to provide EPCMCQV to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
read more
Tuesday, February 04, 2025
Jabil Inc. announced the acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid...
read more
Wednesday, November 18, 2020
J. Knipper and Company has finalized a transaction to acquire Eagle Pharmacy, a direct-to-patient pharmacy based in Lakeland, Florida.
read more
Thursday, December 14, 2017
Izana Bioscience has launched as a new clinical-stage translational medicine company.
read more
Tuesday, January 27, 2026
iXCells Biotechnologies and Rosebud Biosciences announced a partnership to develop a personalized, human-based approach for predicting drug safety and informing translational decision-making in rare diseases.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Monday, November 20, 2017
ITUS has entered into a CRADA with Moffitt Cancer Center, to advance toward human clinical testing, a Chimeric Antigen Receptor T-Cell technology.
read more